PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Pregabalin - Restless Leg Syndrome

PAD Profile : Pregabalin - Restless Leg Syndrome

Brand Names Include :
Lyrica

Traffic Light Status

Status 1 of 1.

Status :
Green
Important Preferred
Formulations :
  • Capsules
Important Information :
Patients with severe sleep disturbance, RLS-related / co-morbid pain or history of impulse control disorder
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
Un
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
07 November 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

Pregabalin is recommended as a FIRST line option for the treatment of Restless Leg Syndrome, as per CKS guidance.

Link to CKS page - https://cks.nice.org.uk/restless-legs-syndrome  

Please note; this is an off-label indication of a licensed medicine.

Associated BNF Codes

04. Central Nervous System
04.07.03. Neuropathic pain
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More